Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gw Pharma ADR (NQ: GWPH )

214.95 USD +0.10 (+0.05%)
Streaming Delayed Price Updated: 11:19 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Gw Pharma ADR

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Hemp's FDA Declassification Opens Door to Massive CBD Market Growth
From PR Newswire
Outside Investment, New Technology Support Growing Cannabis Industry
From CannabisNewsWire
Outside Investment, New Technology Support Growing Cannabis Industry
From PR Newswire
Outside Investment, New Technology Support Growing Cannabis Industry
Tags LXRP News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Targeting CBD-Infused Beverage Market through Recent Exclusive Cross-marketing Agreement
From CannabisNewsWire
Mugglehead reveals a number of stocks set to take advantage of hemp
Hemp. It’s one of the world’s fastest growing plants—a separate species of the cannabis sativa genus that, due to its >0.3% tetrahydrocannabinol (THC) content, makes it literally almost impossible to... 
From GlobeNewswire News Releases
Companies Explore Market Potential for Ready-to-Drink CBD Beverages
From PR Newswire
Companies Explore Market Potential for Ready-to-Drink CBD Beverages
Tags YGYI News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
Kali-Extracts, Inc. Releases Preclinical Research Study Results on Therapy for Respiratory Disease Driving $11 Billion Treatment Market
From PR Newswire
CannabisNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Leveraging its Proprietary Bioavailability-enhancing Technology to Target Consumable CBD Market
From CannabisNewsWire
Investor Expectations to Drive Momentum within ANSYS, Nordic American Tankers, Woodward, GW Pharmaceuticals, CareTrust REIT, and TOCAGEN INC — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ANSYS, Inc. (NASDAQ:ANSS),... 
From GlobeNewswire News Releases
Booming Cannabis Consumables Space Continues to see Product Innovations
From CannabisNewsWire
Booming Cannabis Consumables Space Continues to see Product Innovations
CannabisNewsWire Editorial Coverage 
From PR Newswire
Booming Cannabis Consumables Space Continues to see Product Innovations
Tags LXRP News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the... 
From GlobeNewswire News Releases
Expansion of CBD - Hemp Operations Continues to Explode as Demand and Sales Revenues Climb
From PR Newswire
Expansion of CBD – Hemp Operations Continues to Explode as Demand and Sales Revenues Climb
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: “GWP,” “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its... 
From GlobeNewswire News Releases
FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer
FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly accomplished healthcare... 
From Business Wire News Releases
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting
Meeting Highlights Include over 20 Posters and Virtual Tour of the Epidiolex Manufacturing Process 
From GlobeNewswire News Releases
CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Employs Vertically Integrated Strategy in the Cannabis Market
From CannabisNewsWire
Growing Cannabis Industry Creates Space for New Strategies
From CannabisNewsWire
Growing Cannabis Industry Creates Space for New Strategies
From PR Newswire
Growing Cannabis Industry Creates Space for New Strategies
Tags YGYI News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Trending News: Legal Cannabis Market Rallies on Favorable Political Developments
FinancialBuzz.com News Commentary 
From PR Newswire
GW Pharmaceuticals to Report Fourth Quarter and Year-End Financial Results and Host Conference Call on 27 November, 2018
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
Payment Solutions Among Innovations in the Fast-Growing Cannabis Industry
From PR Newswire
Payment Solutions Among Innovations in the Fast-Growing Cannabis Industry
From CannabisNewsWire
Payment Solutions Among Innovations in the Fast-Growing Cannabis Industry
Tags NNW News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.